Source document: https://docs-lawep.s3.us-east-2.amazonaws.com/1697642326411.pdf (Bahamas)
EXTRAORDINARY OFFICIAL GAZETTE THE BAHAMAS PUBLISHED BY AUTHORITY NASSAU l2'h March, 2012 TABLE OF CONTENTS S.l.

No.
TITLE PAGE 32 33 34 35 The National Insurance (Chronic Diseases Prescription Drug Fund) Act, 2009 (Amendment to Schedule) Order, 2012 The National Insurance (Chronic Diseases Prescription Drug Fund) Act, 2009 (Amendment) Regulations, 2012 The National Insurance (Contributions) (Amendment) Regulations, 2012 The National Insurance (Benefit and Assistance) (Amendment) Regulations, 2012 2 4 8 11 NATIONAL INSURANCE (CHRONIC DISEASES PRESCRIPTION DRUG FUND)(AMENDMENT) REGULATIONS, 2012 Arrangement of Regulations Regulation I.
2.

3.

Citation ...................................................... ............................................................. 2 Amendment to Fifth Schedule of the principal Regulations ...... ........................... 2 Deletion of regulation 9 of the principal Regulations .............. .................... .......... 4 S.I.

No.

33 of2012 NATIONAL INSURANCE (CHRONIC DISEASES PRESCRIPTION DRUG FUND) ACT, 2009 (No.
41 of 2009) NATIONAL INSURANCE (CHRONIC DISEASES PRESCRIPTION DRUG FUND)(AMENDMENT) REGULATIONS, 2012 The Minister, in exercise of the powers conferred by section ll of the National Insurance Chronic Diseases (Prescription Drug Fund) Act, 2009, makes the following Regulations - 1.

Citation.
Citation.

These Regulations, which amend the National Insurance (Chronic Diseases Prescription Drug Fund) Regulations 1 may be cited as the National Insurance (Chronic Diseases Prescription Drug Fund)(Amendment) Regulations, 2012.

2.

Amendment to Fifth Schedule of the principal Regulations.
In the Fifth Schedule to the principal Regulations- (a) insert in the appropriate alphabetical order, the following new classes of prescription drugs and medical supplies under the Plan - "BENIGN PROSTATE HYPERTROPHY (BPH) Alpha-!

Adrenergic Blockers 5-Alpha Reductase Inhibitors EPILEPSY Dibenzazepine Carboxamides Hydantoins Gamma Aminobutyric Acids Phenyltriazines Barbiturates *SAM Valproic Acids 'S.

I.

No.

89 of2010.
I.

No.

89 of2010.

Page - 2 Fructopyranose Sulfamates SICKLE CELLANEMIA Antimetabolites Non-steroidal Anti-inflammatory Drugs.
NSAIDS THYROID DISEASE (HYPERTHYROID AND HYPOTHYROID) Antithyroid Agents Thyroid Supplements"; (b) the medical condition "HYPERTENSION", under following new drug class - insert the Alpha-I Adrenergic Blockers"; (c) under the medical condition "DIABETES", insert the following new drug class- Dipeptidyl Peptidase 4 (DDP~4) Inh ibitors"; (d) substitute the medical condition "ISCHAEMIC HEART DISEASE" with the words "ISCHAEMIC DISEASE" and add the following new drug dasses thereunder - Anticoagulants Flavonoid Vasoprotectors Methylxanthines"; (e) substitute the medical condition "MAJOR DEPRESSION" with the words "PSYCHIATRIC ILLNESS" and add the following new drug classes thereunder- Anti-cholinergics Phenothiazines Typical Antipsychotics Atypical Antipsychotics"; and (f) the medical condition "PSYCHOSIS" and all of the delete particulars relating thereunder.
Page- 3 3.

Deletion of regulation 9 of the principal Regulations.

The principal Regulations is amended by the deletion of regulation 9.

Made this l21 h day of March, 2012.

Signed HUBERT A. INGRAHAM Minister responsible for National Insurance Page- 4